d-alpha tocopherol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; Li, M; Long, Y; Ren, K; Wang, Y; Xiang, B; Yang, Y; Zhang, Z | 1 |
| Chen, YH; Hung, YT; Wei, CW; Yiang, GT; Yu, YL | 1 |
| Hung, YT; Liu, HC; Lu, JY; Wei, CW; Yiang, GT; Yu, YL | 1 |
| Chen, X; Fang, K; Gao, X; Gong, J; Guo, D; Hu, S; Ji, H; Jiang, S; Lv, Y; Peng, L; Song, X; Yang, F; Zhang, J; Zhang, Y; Zuo, R | 1 |
| Ahmad, FJ; Akhter, S; Garg, N; Kumar Jain, G; Selvapandiyan, A; Zafar, S | 1 |
| Fang, K; Gao, X; Guo, D; Hu, S; Ji, C; Ji, H; Jiang, S; Li, G; Peng, L; Si, H; Song, X; Wang, J; Zhang, J; Zuo, R | 1 |
| Assumpção, JAF; Correa, LH; Ito, MK; Kiffer, LFMV; Luzete, BC; Magalhães, KG; Melo, HAB; Pizato, N; Sant'Ana, LP | 1 |
| Feng, SS; Kutty, RV | 1 |
| Kline, K; Liu, Y; Sanders, BG; Xiong, A; Yu, W | 1 |
| Chia, SL; Feng, SS; Kutty, RV; Leong, DT; Muthu, MS; Setyawati, MI | 1 |
10 other study(ies) available for d-alpha tocopherol and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles.
Topics: alpha-Tocopherol; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Heparin, Low-Molecular-Weight; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Micelles; Neoplasm Metastasis; Particle Size; Triple Negative Breast Neoplasms | 2020 |
Anticancer effects of methotrexate in combination with α‑tocopherol and α‑tocopherol succinate on triple‑negative breast cancer.
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Methotrexate; Triple Negative Breast Neoplasms | 2019 |
Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells.
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; MAP Kinase Kinase 4; Signal Transduction; Sulfasalazine; Triple Negative Breast Neoplasms | 2019 |
Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Humans; Mice; Mice, Nude; Micelles; Piperidines; Polymers; Quinazolinones; Triple Negative Breast Neoplasms; Vitamin E | 2022 |
Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Phosphatidylethanolamines; Polyethylene Glycols; Triple Negative Breast Neoplasms; Vitamin E | 2020 |
Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Female; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Piperidines; Polymers; Quinazolinones; Reactive Oxygen Species; Treatment Outcome; Triple Negative Breast Neoplasms; Vitamin E | 2021 |
Omega 3-DHA and Delta-Tocotrienol Modulate Lipid Droplet Biogenesis and Lipophagy in Breast Cancer Cells: the Impact in Cancer Aggressiveness.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Movement; Docosahexaenoic Acids; Female; Humans; Lipid Droplets; Perilipin-2; Reactive Oxygen Species; Signal Transduction; Triple Negative Breast Neoplasms; Vitamin E | 2019 |
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Line, Tumor; Cetuximab; Docetaxel; Humans; Mice; Micelles; Nanomedicine; Nanotechnology; Taxoids; Triple Negative Breast Neoplasms; Vitamin E | 2013 |
Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.
Topics: Aldehyde Dehydrogenase; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chromans; Docosahexaenoic Acids; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Vitamin E | 2016 |
In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Cell Line, Tumor; Cetuximab; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; Mice, SCID; Micelles; Polyethylene Glycols; Taxoids; Triple Negative Breast Neoplasms; Vitamin E | 2015 |